The Treatment of Metastatic Colorectal Cancer

C. S. Karapetis, D. Yip, Peter G. Harper

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Metastatic colorectal cancer represents an incurable condition, with the exception of a very select group of patients in whom surgical excision of recurrent disease is possible. Chemotherapy offers a significant palliative benefit and may prolong patient survival. The preferred cytotoxic agent is 5-fluorouracil, though the optimal administration schedule is unknown. Recent evidence also supports the use of second-line chemotherapy for patients who develop progressive disease following 5-fluorouracil treatment. Promising results have been obtained with new drugs, in particular oxaliplatin and irinotecan. Novel therapeutic approaches, including immunotherapy and liver directed strategies, are undergoing clinical evaluation. Comprehensive supportive care, with appropriate community and hospital based palliative care, is essential in the management of patients with advanced colorectal cancer.

Original languageEnglish
Pages (from-to)287-294
Number of pages8
JournalInternational Journal of Clinical Practice
Volume53
Issue number4
Publication statusPublished - Jun 1999
Externally publishedYes

Fingerprint Dive into the research topics of 'The Treatment of Metastatic Colorectal Cancer'. Together they form a unique fingerprint.

  • Cite this

    Karapetis, C. S., Yip, D., & Harper, P. G. (1999). The Treatment of Metastatic Colorectal Cancer. International Journal of Clinical Practice, 53(4), 287-294.